Fidelity Investments’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-333
| Closed | -$220 | – | 5804 |
|
|
2024
Q2 | $220 | Buy |
+333
| New | +$207 | ﹤0.01% | 4916 |
|
|
2023
Q4 | – | Sell |
-7
| Closed | -$5 | – | 5696 |
|
|
2023
Q3 | $5 | Sell |
7
-904
| -99% | -$1.11K | ﹤0.01% | 5228 |
|
|
2023
Q2 | $3K | Buy |
911
+426
| +88% | +$1.29K | ﹤0.01% | 4498 |
|
|
2023
Q1 | $4.41K | Sell |
485
-78
| -14% | -$1.1K | ﹤0.01% | 4426 |
|
|
2022
Q4 | $6.61K | Buy |
563
+32
| +6% | +$564 | ﹤0.01% | 4160 |
|
|
2022
Q3 | $11K | Sell |
531
-93
| -15% | -$2.51K | ﹤0.01% | 4070 |
|
|
2022
Q2 | $15K | Buy |
624
+212
| +51% | +$7.21K | ﹤0.01% | 3986 |
|
|
2022
Q1 | $21K | Buy |
+412
| New | +$20.4K | ﹤0.01% | 4004 |
|
|
2021
Q4 | – | Sell |
-28
| Closed | -$3K | – | 5052 |
|
|
2021
Q3 | $3K | Buy |
+28
| New | +$2.66K | ﹤0.01% | 3947 |
|
|
2019
Q2 | – | Sell |
-73
| Closed | -$4K | – | 4260 |
|
|
2019
Q1 | $4K | Buy |
+73
| New | +$3.95K | ﹤0.01% | 3325 |
|
Fidelity Investments's VBIV Position: Q3 2024 in Review
Fidelity Investments sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 333 shares — an estimated $220 sold.
Fidelity Investments first reported a position in VBIV in Q1 2019 and held it in 10 quarters. The position peaked at $21K in Q1 2022. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- Fidelity Investments reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- Fidelity Investments sold 333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $220.
- Fidelity Investments first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2019 and held it in 10 quarters.
- Fidelity Investments's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $21K in Q1 2022.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on Fidelity Investments's 13F filing for Q3 2024, filed 13 Nov 2024.